강희철

This profile gathers the share dealings of 강희철 in 지에프씨생명과학, where the filings describe the role as chief executive. The record holds 44 filings, for trades running from 28 December 2022 to 16 September 2026.

On the open market, the record shows 20 purchases worth €241k and 1 sale. The totals exclude 14 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2026, the count stands at 17 purchases and no sales.

The median purchase comes to €29k. As a share of market capitalisation, the median purchase stands at 0.15%, based on 7 purchases. 5 out of 12 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. For 7 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -45.3%. These figures describe past trades and do not predict future prices.

The newest entry dates from 16 September 2026: a transaction, in 지에프씨생명과학. The last purchase on record was published on 4 September 2026, which is 44 days ago. Filings reach the DART (FSS) feed a median of 4 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.